Improving survival in patients with decompensated cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 11, 2010, Pages 1716-1717

  Amarapurkar, Deepak ^a   Sanyal, Arun ^b  

^a BOMBAY HOSPITAL   (India)

^b VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ANTIBIOTIC PROPHYLAXIS; ASCITES; BACTERIAL PERITONITIS; BARE METAL STENT; BLEEDING; CELL MIGRATION; COST BENEFIT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; ENDOSCOPIC THERAPY; FENESTRATION; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; NOTE; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; SURVIVAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 78149270953     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06515.x     Document Type: Note

References (8)

1. Sanyal AJ, Freedman AM, Luketic VA et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111: 138-46.
2. Sanyal AJ, Genning C, Reddy KR et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634-41.
3. Gines P, Uriz J, Calahorra B et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-47.
4. Sanyal AJ, Freedman AM, Luketic VA etal. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889-98.
5. Sanyal AJ, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology 1998; 28: 22-32.
6. Sanyal AJ, Mirshahi F. Endothelial cells lining transjugular intrahepatic portasystemic shunts originate in hepatic sinusoids: implications for pseudointimal hyperplasia. Hepatology 1999; 29: 710-8.
7. Yang Z, Han G, Wu Q, Ye X et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunts with polytetrafluoroethylene-covered stents versus bare stents: A meta analysis. J. Gastroenterol. Hepatol. 2010; 25: 1718-25.
8. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell. Mol. Life Sci. 2005; 62: 2295-304.